The presence of liver fibrosis after three weeks of CCl4 treatment was confirmed by a hematoxylin and eosin (H&E) stain as well as α smooth muscle actin (α-SMA) immunohistochemistry on FFPE tissue sections (Figure 1A). The gene discussed is ACTA1; the disease is Hepatic fibrosis.